Advertisement
Canada markets close in 3 hours 20 minutes

  • S&P/TSX

    21,768.37
    +59.93 (+0.28%)
     

  • S&P 500

    4,966.86
    -44.26 (-0.88%)
     

  • DOW

    37,837.97
    +62.59 (+0.17%)
     

  • CAD/USD

    0.7269
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    82.95
    +0.22 (+0.27%)
     

  • Bitcoin CAD

    87,646.55
    -81.48 (-0.09%)
     

  • CMC Crypto 200

    1,370.89
    +58.27 (+4.44%)
     

  • GOLD FUTURES

    2,406.00
    +8.00 (+0.33%)
     

  • RUSSELL 2000

    1,938.62
    -4.34 (-0.22%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,314.74
    -286.76 (-1.84%)
     

  • VOLATILITY

    19.00
    +1.00 (+5.56%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     
MARKETS LIVE BLOG:

S&P 500 SLIPS BELOW 5,000; NASDAQ SINKS ON NETFLIX DRAG

Fed's Goolsbee says 'It makes sense to wait' before cutting rates

Five Star Equities Issues New Research Reports on MKC, PFE, SWHC and WAG

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

McCormick & Company, Inc. (NYSE:MKC - News) shares spiked 5.47 percent to close at $71.20 a share Tuesday. The stock traded between $70.02 and $71.99 on volume 1.64million shares traded. The company reported earnings per share was $0.62 for the first quarter of fiscal 2014, an increase of 9.0 percent when compared to a year ago. Shares of McCormick & Company are up approximately 3.0 percent year-to-date.

Get more information on McCormick & Company free access to the in-depth equity report at:
www.FiveStarEquities.com/MKC

Pfizer Inc. (NYSE:PFE - News) shares increased 1.05 percent to close at $31.82 a share Tuesday. The stock traded between $31.59 and $31.99 on volume of 21.14 million shares traded. The company announced that its Xalkori cancer drug met its primary objective of significantly prolonging progression-free survival when compared to chemotherapy in a recent study. Shares of Pfizer are up approximately 4.0 percent year-to-date.

ADVERTISEMENT

Get more information on Pfizer and free access to the in-depth equity report at:
www.FiveStarEquities.com/PFE

Smith & Wesson Holding Corp. (NASDAQ:SWHC - News) shares gained 1.37 percent to close at $14.01 a share Tuesday. The stock traded between $13.92 and $14.24 on volume of 1.34 million shares traded. The company announced that its newly formed subsidiary, Deep River Plastics, LLC, has acquired Tri Town Precision Plastics, Inc. for roughly $23.0 million. Shares of Smith & Wesson are up approximately 4.0 percent year-to-date.

Get more information on Smith & Wesson and free access to the in-depth equity report at:
www.FiveStarEquities.com/SWHC

Walgreen Company (NYSE:WAG - News) shares gained 3.28 percent to close at $66.42 a share Tuesday. The stock traded between $65.56 and $68.15 on volume 12.81 million shares traded. The company reported revenues were a record $19.6 billion for the second quarter of fiscal 2014, an increase of 5.1 percent when compared to a year ago. Shares of Walgreens are up approximately 16.0 percent year-to-date.

Get more information on Walgreens and free access to the in-depth equity report at:
www.FiveStarEquities.com/WAG

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com